31 results on '"Hargreaves, April"'
Search Results
2. Online learning predictors of mental health in third-level students during the COVID-19 pandemic in Ireland.
3. Challenges in Using Social Media as a Recruitment Platform for an Unfunded Nationwide Online Survey: Irish Public’s Perception of the Disorders of Schizophrenia, Bipolar Disorder, and Autism
4. Variability in Working Memory Performance Explained by Epistasis vs Polygenic Scores in the ZNF804A Pathway
5. Knowledge, attitudes, and behaviours towards schizophrenia, bipolar disorder, and autism: a pilot study.
6. No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial
7. The phenotypic manifestations of rare CNVs in schizophrenia
8. Online learning predictors of mental health in third-level students during the COVID-19 pandemic in Ireland
9. Independent Computerized Cognitive Remediation for Psychosis: An Investigation of Patient Experiences
10. Knowledge, attitudes, and behaviours towards schizophrenia, bipolar disorder, and autism: a pilot study
11. Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style
12. Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253
13. Social cognition in bipolar disorder versus schizophrenia: comparability in mental state decoding deficits
14. T58. EFFECTIVENESS OF ORALLY ADMINISTERED CO-ENZYME Q10 FOR SCHIZOPHRENIA: COGNITIVE, FUNCTIONAL AND BIOCHEMICAL OUTCOMES FROM A DOUBLE BLIND, RANDOMISED, PLACEBO CONTROLLED TRIAL
15. Coenzyme Q10 and neuropsychiatric and neurological disorders: relevance for schizophrenia
16. Coenzyme Q10 and neuropsychiatric and neurological disorders: relevance for schizophrenia.
17. Computerised working memory‐based cognitive remediation therapy does not affect Reading the Mind in The Eyes test performance or neural activity during a Facial Emotion Recognition test in psychosis
18. T69. PERFORMANCE OF PATIENTS WITH NMDAR-AB ENCEPHALITIS COMPARED TO PATIENTS WITH SCHIZOPHRENIA AND HEALTHY CONTROLS USING FUNCTIONAL MAGNETIC RESONANCE IMAGING (F-MRI) AND A WORKING MEMORY PARADIGM
19. S83. THE IMPACT OF COENZYME Q10 ON THE COGNITIVE DEFICITS AND SYMPTOMS OF SCHIZOPHRENIA: PROTOCOL AND BASELINE DATA OF A RANDOMISED, PLACEBO-CONTROLLED STUDY
20. S65. INDEPENDENT COMPUTERISED COGNITIVE REMEDIATION FOR PSYCHOSIS: AN INVESTIGATION OF PATIENT EXPERIENCES
21. Coenzyme Q10: From Fact to Fiction
22. S02. Delineation of a recognisable phenotype of interstitial deletion 3 (q22.3q25.1) in a case with previously unreported truncus arteriosus
23. Adherence to a Low-Support Cognitive Remediation Training Program for Psychosis
24. Social dysfunction in schizophrenia: An investigation of the GAF scale's sensitivity to deficits in social cognition
25. A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809
26. Effects of a novel schizophrenia risk variant rs7914558 atCNNM2on brain structure and attributional style
27. The Role of the Major Histocompatibility Complex Region in Cognition and Brain Structure: A Schizophrenia GWAS Follow-Up
28. Poster #116 ZNF804A AND SOCIAL COGNITION IN PATIENTS WITH SCHIZOPHRENIA AND HEALTHY PARTICIPANTS
29. Neural effects of the CSMD 1 genome-wide associated schizophrenia risk variant rs10503253.
30. Neural effects of the CSMD1genome‐wide associated schizophrenia risk variant rs10503253
31. EFFECTIVENESS OF ORALLY ADMINISTERED CO-ENZYME Q10 FOR SCHIZOPHRENIA: COGNITIVE, FUNCTIONAL AND BIOCHEMICAL OUTCOMES FROM A DOUBLE BLIND, RANDOMISED, PLACEBO CONTROLLED TRIAL.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.